DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
Clinical trial NCT03110354 · TERMINATED
Trial details
- NCT number
- NCT03110354
- Sponsor
- Daiichi Sankyo
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-05
- Primary completion
- 2021-03-09
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.